Reuters

03 Jun 2026, 13:19 UTC · 1h ago

US FDA to review AI-based tool to predict drug-related liver damage

Read original · https://www.reuters.com/legal/litigation/us-fda-review-ai-based-tool-predict-drug-related-liver-damage-2026-06-03/

Search tags

Story key points

1 claims · impact-rated

What matters in this story

1
The FDA has accepted a letter of intent for an AI-based tool designed to predict drug-induced liver injury. — Integrating AI into the drug development pipeline could significantly reduce clinical trial failure rates and lower R&D costs for pharmaceutical companies.
+0.40

Ticker attribution

Model heads

Sentiment in this article

No ticker sentiment head found.

Relationships in this article

No ticker relationship head found.

Early access

You’re reading about it. Someone else is already positioned.

News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.

Browse live screenings

Impact vectors

4 dimensions · 9 clusters

Analytical profile by cluster

6 related stories

Business Wire
1h ago
Huron Acquires RelateCare to Strengthen Patient Access and Care Coordination Capabilities
- ai
- healthcare
Read

US FDA to review AI-based tool to predict drug-related liver damage |… · News Impact Screener

US FDA to review AI-based tool to predict drug-related liver damage

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Huron Acquires RelateCare to Strengthen Patient Access and Care Coordination Capabilities

US FDA to review AI-based tool to predict drug-related liver damage

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Huron Acquires RelateCare to Strengthen Patient Access and Care Coordination Capabilities

Top impact dimensions

Most positively impacted

Most negatively impacted

Private sector adds 122,000 jobs in May, above expectations, ADP says

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Alphabet's New $80B Spending: What AI Stock To Buy

3 Most Upgraded Stocks Last Month According to MarketBeat

US FDA to review AI-based tool to predict drug-related liver damage

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Next reads from the same story arc

Huron Acquires RelateCare to Strengthen Patient Access and Care Coordination Capabilities

US FDA to review AI-based tool to predict drug-related liver damage

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Next reads from the same story arc

Huron Acquires RelateCare to Strengthen Patient Access and Care Coordination Capabilities

Top impact dimensions

Most positively impacted

Most negatively impacted

Private sector adds 122,000 jobs in May, above expectations, ADP says

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Alphabet's New $80B Spending: What AI Stock To Buy

3 Most Upgraded Stocks Last Month According to MarketBeat